Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Mindfulness-based Relapse Prevention With or Without Vortioxetine on the Prevention of Relapse in Chronic Methamphetamine Users

NCT03830827 is registered in ClinicalTrials.gov with Sir Run Run Shaw Hospital as lead sponsor.

NCT NCT03830827
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03830827 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Mindfulness-based Relapse Prevention With or Without Vortioxetine on the Prevention of Relapse in Chronic Methamphetamine Users
Lead sponsor
Sir Run Run Shaw Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
September 1, 2020
Completion date
April 30, 2021
Enrollment
220 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive impairment, depression, relapse